Clinical Laboratory Improvement Advisory Committee (CLIAC)

---
identifier: "/us/fr/2017-05731"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Clinical Laboratory Improvement Advisory Committee (CLIAC)"
title_number: 0
title_name: "Federal Register"
section_number: "2017-05731"
section_name: "Clinical Laboratory Improvement Advisory Committee (CLIAC)"
positive_law: false
currency: "2017-03-23"
last_updated: "2017-03-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-05731"
document_type: "notice"
publication_date: "2017-03-23"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "82 FR 14901"
fr_volume: 82
---


#  Clinical Laboratory Improvement Advisory Committee (CLIAC)

*Notice of Cancellation:* This notice was published in the *Federal Register* on March 9, 2017, Volume 82, Number 45, page 13121. The meeting previously scheduled to convene on April 12-13, 2017, has been canceled.

*Contact Person for Additional Information:* Nancy Anderson, Chief, Laboratory Practice Standards Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, CDC, 1600 Clifton Road NE., Mailstop F-11, Atlanta, Georgia 30329-4018; telephone (404) 498-2741; or via email at *[email protected].*

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.